Related Experiment Video
Updated: Mar 2, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Phosphonated Pillar[5]arene-Valved Mesoporous Silica Drug Delivery Systems
Xuan Huang1, Shanshan Wu1, Xiaokang Ke1
1Key Laboratory of Mesoscopic Chemistry (Ministry of Education), State Key Laboratory of Coordination Chemistry, Collaborative Innovation Center of Chemistry for Life Sciences, and School of Chemistry and Chemical Engineering, Nanjing University , Nanjing 210023, P. R. China.
Researchers developed novel supramolecular nanovalves using phosphonated pillar[5]arenes (PPA[5]) for drug delivery. These PPA[5]-based nanovalves offer controlled release and enhanced antitumor efficacy, particularly with gold nanorod-embedded systems for photothermo-chemotherapy.
Area of Science:
- Supramolecular Chemistry
- Nanotechnology
- Materials Science
Background:
- Pillararene-based molecular machines offer diverse applications.
- Mesoporous silica nanoparticles (MSNs) are widely used for drug delivery.
- Developing advanced nanocarriers with controlled release mechanisms is crucial for effective therapeutics.
Purpose of the Study:
- To synthesize phosphonated pillar[5]arenes (PPA[5]) for constructing novel supramolecular nanovalves.
- To investigate the host-guest interactions for enhanced drug encapsulation and controlled release.
- To evaluate the potential of PPA[5]-based nanovalves, especially when integrated with gold nanorods (GNRs), for tumor photothermo-chemotherapy.
Main Methods:
- Synthesis of phosphonated pillar[5]arenes (PPA[5]).
- Functionalization of mesoporous silica nanoparticles (MSNs) with choline and pyridinium moieties.
- Construction of supramolecular nanovalves by encircling functionalized MSNs with PPA[5].
- Evaluation of drug release triggered by low pH, Zn2+, and competitive agents.
- Assessment of enhanced drug delivery and antitumor efficacy using GNR-embedded MSNs (GNR@MSNs) under near-infrared (NIR) light irradiation.
Main Results:
- Novel supramolecular nanovalves were successfully constructed using PPA[5] and functionalized MSNs.
- PPA[5] demonstrated high binding affinity to quaternary ammonium stalks via ion pairing, minimizing premature drug release.
- Controlled drug release was achieved, and release efficiency was significantly enhanced in GNR@MSNs under NIR light.
- Synergistic photothermo-chemotherapy using PPA[5]-valved GNR@MSNs showed enhanced antitumor efficacy.
Conclusions:
- Phosphonated pillar[5]arenes are effective in constructing robust supramolecular nanovalves for drug delivery.
- The ion-pairing interaction between PPA[5] and quaternary ammonium moieties provides a stable yet triggerable drug delivery system.
- The PPA[5]-valved GNR@MSN system holds significant promise for advanced tumor photothermo-chemotherapy applications.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Stimuli-Activated
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Classification

